Elizabeth WoldeMussie

2.7k total citations
45 papers, 2.2k citations indexed

About

Elizabeth WoldeMussie is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Elizabeth WoldeMussie has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Ophthalmology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Elizabeth WoldeMussie's work include Glaucoma and retinal disorders (20 papers), Retinal Development and Disorders (14 papers) and Receptor Mechanisms and Signaling (9 papers). Elizabeth WoldeMussie is often cited by papers focused on Glaucoma and retinal disorders (20 papers), Retinal Development and Disorders (14 papers) and Receptor Mechanisms and Signaling (9 papers). Elizabeth WoldeMussie collaborates with scholars based in United States, Ireland and Australia. Elizabeth WoldeMussie's co-authors include Guadalupe Ruíz, Larry A. Wheeler, M Wijono, L. A. Wheeler, Ronald Lai, William A. Hare, Barbara Feldmann, David V. Pow, Michal Schwartz and Eti Yoles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Elizabeth WoldeMussie

45 papers receiving 2.1k citations

Peers

Elizabeth WoldeMussie
Guadalupe Ruíz United States
Iok‐Hou Pang United States
Marcus Karlstetter Germany
Jeffrey H. Boatright United States
Irina Semkova Germany
Carmelo Romano United States
Antje Grosche Germany
Jorge L. Cueva Vargas Canada
Xiaoxi Qiao United States
Natik Piri United States
Guadalupe Ruíz United States
Elizabeth WoldeMussie
Citations per year, relative to Elizabeth WoldeMussie Elizabeth WoldeMussie (= 1×) peers Guadalupe Ruíz

Countries citing papers authored by Elizabeth WoldeMussie

Since Specialization
Citations

This map shows the geographic impact of Elizabeth WoldeMussie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth WoldeMussie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth WoldeMussie more than expected).

Fields of papers citing papers by Elizabeth WoldeMussie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth WoldeMussie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth WoldeMussie. The network helps show where Elizabeth WoldeMussie may publish in the future.

Co-authorship network of co-authors of Elizabeth WoldeMussie

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth WoldeMussie. A scholar is included among the top collaborators of Elizabeth WoldeMussie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth WoldeMussie. Elizabeth WoldeMussie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sullivan, R, Elizabeth WoldeMussie, & David V. Pow. (2007). Dendritic and Synaptic Plasticity of Neurons in the Human Age-Related Macular Degeneration Retina. Investigative Ophthalmology & Visual Science. 48(6). 2782–2782. 84 indexed citations
2.
Wheeler, L. A., Ronald Lai, Elizabeth WoldeMussie, & William A. Hare. (2007). Neuroprotection: new pharmacological targets. Eye. 21(S1). S46–S50. 2 indexed citations
3.
Pow, David V., et al.. (2006). The Glutamate Transporter GLT–1C Is Expressed by Retinal Ganglion Cells in Both Glaucoma and AMD. Investigative Ophthalmology & Visual Science. 47(13). 891–891. 1 indexed citations
4.
WoldeMussie, Elizabeth, M Wijono, & Guadalupe Ruíz. (2004). Müller cell response to laser‐induced increase in intraocular pressure in rats. Glia. 47(2). 109–119. 111 indexed citations
5.
Hare, William A., Elizabeth WoldeMussie, Ronald Lai, et al.. (2004). Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, I: Functional Measures. Investigative Ophthalmology & Visual Science. 45(8). 2625–2625. 107 indexed citations
6.
Wheeler, Larry A., Elizabeth WoldeMussie, & Ronald Lai. (2003). Role of Alpha-2 Agonists in Neuroprotection. Survey of Ophthalmology. 48(2). S47–S51. 102 indexed citations
7.
WoldeMussie, Elizabeth, et al.. (2002). Neuroprotective Effect of Different Formulations of Topically applied Brimonidine after Calibrated Optic Nerve Injury. Investigative Ophthalmology & Visual Science. 43(13). 767–767. 1 indexed citations
8.
WoldeMussie, Elizabeth, Eti Yoles, Michal Schwartz, Guadalupe Ruíz, & Larry A. Wheeler. (2002). Neuroprotective Effect of Memantine in Different Retinal Injury Models in Rats. Journal of Glaucoma. 11(6). 474–480. 94 indexed citations
9.
Hare, William A., Elizabeth WoldeMussie, Guadalupe Ruíz, et al.. (2001). Efficacy and Safety of Memantine, an NMDA-Type Open-Channel Blocker, for Reduction of Retinal Injury Associated with Experimental Glaucoma in Rat and Monkey. Survey of Ophthalmology. 45. S284–S289. 100 indexed citations
10.
Spalding, Tracy A., A. Kharlamb, Niels Skjærbæk, et al.. (2001). Exploring the potential for subtype-selective muscarinic agonists in glaucoma. Life Sciences. 68(22-23). 2601–2604. 8 indexed citations
11.
Wheeler, Larry A., Daniel W. Gil, & Elizabeth WoldeMussie. (2001). Role of Alpha-2 Adrenergic Receptors in Neuroprotection and Glaucoma. Survey of Ophthalmology. 45. S290–S294. 81 indexed citations
12.
Wheeler, L. A., Ronald Lai, & Elizabeth WoldeMussie. (1999). From the Lab to the Clinic: Activation of an Alpha-2 agonist Pathway is Neuroprotective in Models of Retinal and Optic Nerve Injury. European Journal of Ophthalmology. 9(1_suppl). S17–21. 77 indexed citations
13.
Edelman, J. L., Masayoshi Kajimura, Elizabeth WoldeMussie, & George Sachs. (1994). Differential effects of carbachol on calcium entry and release in CHO cells expressing the m3 muscarinic receptor. Cell Calcium. 16(3). 181–193. 12 indexed citations
14.
WoldeMussie, Elizabeth, Barbara Feldmann, & June Chen. (1993). Characterization of Muscarinic Receptors in Cultured Human Iris Sphincter and Ciliary Smooth Muscle Cells. Experimental Eye Research. 56(4). 385–392. 46 indexed citations
15.
WoldeMussie, Elizabeth, et al.. (1992). Effect of histamine on signal transduction in cultured human trabecular meshwork cells. Current Eye Research. 11(10). 987–995. 2 indexed citations
16.
Sauerberg, Per, Jake Y. Chen, Elizabeth WoldeMussie, & Henry Rapoport. (1989). Cyclic carbamate analogs of pilocarpine. Journal of Medicinal Chemistry. 32(6). 1322–1326. 20 indexed citations
17.
Woodward, David F., James A. Burke, Linda Williams, et al.. (1989). Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation.. PubMed. 30(8). 1838–42. 43 indexed citations
18.
WoldeMussie, Elizabeth, et al.. (1988). Signal transduction in cultured bovine and human trabecular meshwork cells by several agents. The FASEB Journal. 2(4). 1845. 2 indexed citations
19.
WoldeMussie, Elizabeth, et al.. (1985). Changes in histidine uptake and histamine synthesis during the growth cycle of rat basophilic leukemia (2H3) cells.. Journal of Pharmacology and Experimental Therapeutics. 232(1). 20–26. 6 indexed citations
20.
Beaven, Michael A., et al.. (1983). Changes in histamine synthetic activity, histamine content and responsiveness to compound 48/80 with maturation of rat peritoneal mast cells.. Journal of Pharmacology and Experimental Therapeutics. 224(3). 620–626. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guadalupe Ruíz Breakdown of academic impact, for papers by Iok‐Hou Pang Breakdown of academic impact, for papers by Marcus Karlstetter Breakdown of academic impact, for papers by Jeffrey H. Boatright Breakdown of academic impact, for papers by Irina Semkova Breakdown of academic impact, for papers by Carmelo Romano Breakdown of academic impact, for papers by Antje Grosche Breakdown of academic impact, for papers by Jorge L. Cueva Vargas Breakdown of academic impact, for papers by Xiaoxi Qiao Breakdown of academic impact, for papers by Natik Piri
Rankless by CCL
2026